|
Impax to Sell Generic Renvela, Renagel in 2014 After Genzyme Settlement
Impax Laboratories can market generic versions of Genzyme’s kidney disease drugs Renvela and Renagel in 2014 under a settlement with the brand drugmaker.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives